Flavonoids, a ubiquitous dietary phenolic subclass, exert extensive in vitro anti-invasive and in vivo anti-metastatic activities (Q37982235)

26 August 2017

Flavonoids, a ubiquitous dietary phenolic subclass, exert extensive in vitro anti-invasive and in vivo anti-metastatic activities (English)

1 reference

26 August 2017

Chia-Jui Weng

1

1 reference

PubMed ID

22314287

26 August 2017

Gow-Chin Yen

series ordinal

2

1 reference

26 August 2017

1 June 2012

1 reference

Cancer and Metastasis Reviews

26 August 2017

1 reference

26 August 2017

31

1 reference

26 August 2017

323-351

1 reference

26 August 2017

1-2

1 reference

https://scigraph.springernature.com/pub.10.1007/s10555-012-9347-y

26 August 2017

0 references

cites work

Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Intravital imaging of cell movement in tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Antioxidants in food and food antioxidants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Biotechnology of flavonoids and other phenylpropanoid-derived natural products. Part I: Chemical diversity, impacts on plant biology and human health.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Suppression of cancer invasiveness by dietary compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Chemopreventive effects of dietary phytochemicals against cancer invasion and metastasis: phenolic acids, monophenol, polyphenol, and their derivatives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

New signals from the invasive front

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Epithelial-mesenchymal transitions in tumour progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Expression of E-cadherin, alpha- and beta-catenins in patients with pancreatic adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

N-cadherin expression and epithelial-mesenchymal transition in pancreatic carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Sequential changes in cadherin-catenin expression associated with the progression and heterogeneity of primary oesophageal squamous carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

P-cadherin in adhesion and invasion: opposite roles in colon and bladder carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

The prognostic significance of P-cadherin in infiltrating ductal breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

P-cadherin is up-regulated by the antiestrogen ICI 182,780 and promotes invasion of human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Prognostic impact of alterations in P-cadherin expression and related cell adhesion markers in endometrial cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

A switch from E-cadherin to N-cadherin expression indicates epithelial to mesenchymal transition and is of strong and independent importance for the progress of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Identification of a novel tumor-associated antigen, cadherin 3/P-cadherin, as a possible target for immunotherapy of pancreatic, gastric, and colorectal cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Slug confers resistance to the epidermal growth factor receptor tyrosine kinase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

The emerging roles of forkhead box (Fox) proteins in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Interaction of the DF3/MUC1 breast carcinoma-associated antigen and beta-catenin in cell adhesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

MUC1 oncoprotein blocks glycogen synthase kinase 3beta-mediated phosphorylation and degradation of beta-catenin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

MUC1 enhances invasiveness of pancreatic cancer cells by inducing epithelial to mesenchymal transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Illuminating the metastatic process

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Cofilin promotes actin polymerization and defines the direction of cell motility

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Matrix metalloproteinases and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Tumour-cell invasion and migration: diversity and escape mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Molecular mechanisms of glioma invasiveness: the role of proteases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human pancreatic adenocarcinomas: clinicopathologic and prognostic significance of matrilysin expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Enhanced expression of matrix metalloproteinase-9 by hepatitis B virus infection in liver cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

MMP-9 and MMP-2 gelatinases and TIMP-1 and TIMP-2 inhibitors in breast cancer: correlations with prognostic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

The urokinase plasminogen activator receptor (uPAR) as a target for the diagnosis and therapy of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

The urokinase plasminogen activator system in cancer: recent advances and implication for prognosis and therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Plasminogen activator inhibitor type 2 in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Plasminogen activator inhibitor-1 as a potential marker for the malignancy of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

RECK expression in osteosarcoma: correlation with matrix metalloproteinases activation and tumor invasiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Localized prostate cancer: can we better define who is at risk of unfavourable outcome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Biology of prostate-specific antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

The distribution of secondary growths in cancer of the breast. 1889

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

An address system in the vasculature of normal tissues and tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Metadherin, a cell surface protein in breast tumors that mediates lung metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Involvement of chemokine receptors in breast cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Phosphorylation of the vasodilator-stimulated phosphoprotein regulates its interaction with actin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Mathematical modelling of dynamic adaptive tumour-induced angiogenesis: clinical implications and therapeutic targeting strategies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Tumorigenesis and the angiogenic switch

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Basement membranes: structure, assembly and role in tumour angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Role of Angiopoietins and Tie receptor tyrosine kinases in angiogenesis and lymphangiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

The human side of hypoxia-inducible factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Hypoxia--a key regulatory factor in tumour growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Hypoxia-driven selection of the metastatic phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Targeting HIF-1 for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Evaluation of HIF-1 inhibitors as anticancer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Inhibiting hypoxia-inducible factor 1 for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Tumor metastasis: mechanistic insights and clinical challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Tea polyphenols for health promotion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Beneficial effects of green tea: a literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Antiangiogenic mechanisms of diet-derived polyphenols

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Targeting multiple signaling pathways by green tea polyphenol (-)-epigallocatechin-3-gallate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Green tea polyphenol epigallocatechin-3-gallate inhibits thrombin-induced hepatocellular carcinoma cell invasion and p42/p44-MAPKinase activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Phenolic phytochemicals derived from red pine (Pinus densiflora) inhibit the invasion and migration of SK-Hep-1 human hepatocellular carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Green tea polyphenol epigallocatechin-3-gallate suppresses rat hepatic stellate cell invasion by inhibition of MMP-2 expression and its activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Suppression of adhesion and invasion of hepatoma cells in culture by tea compounds through antioxidative activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Inhibition of hepatoma cell invasion beneath mesothelial-cell monolayer by sera from tea- and related component-treated rats and their modes of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Repressions of MMP-9 expression and NF-kappa B localization are involved in inhibition of lung carcinoma 95-D cell invasion by (-)-epigallocatechin-3-gallate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Epigallocatechin-3-gallate (EGCG) inhibits the migratory behavior of tumor bronchial epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Activation of FOXO3a by the green tea polyphenol epigallocatechin-3-gallate induces estrogen receptor alpha expression reversing invasive phenotype of breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Green tea polyphenol and epigallocatechin gallate induce apoptosis and inhibit invasion in human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Epigallocatechin-3-gallate (EGCG) downregulates EGF-induced MMP-9 in breast cancer cells: involvement of integrin receptor α5β1 in the process

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Green tea polyphenols modulate secretion of urokinase plasminogen activator (uPA) and inhibit invasive behavior of breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Green tea (-)-epigallocatechin-3-gallate down-regulates VASP expression and inhibits breast cancer cell migration and invasion by attenuating Rac1 activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Multifunctional effect of epigallocatechin-3-gallate (EGCG) in downregulation of gelatinase-A (MMP-2) in human breast cancer cell line MCF-7.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Inhibitory effect of (-)-epigallocatechin and (-)-epigallocatechin gallate against heregulin beta1-induced migration/invasion of the MCF-7 breast carcinoma cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

(-)-Epigallocatechin-3-gallate down-regulates EGFR, MMP-2, MMP-9 and EMMPRIN and inhibits the invasion of MCF-7 tamoxifen-resistant cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

The green tea catechins, (-)-Epigallocatechin-3-gallate (EGCG) and (-)-Epicatechin-3-gallate (ECG), inhibit HGF/Met signaling in immortalized and tumorigenic breast epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Treatment of epigallocatechin-3-gallate inhibits matrix metalloproteinases-2 and -9 via inhibition of activation of mitogen-activated protein kinases, c-jun and NF-kappaB in human prostate carcinoma DU-145 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Green tea polyphenol EGCG sensitizes human prostate carcinoma LNCaP cells to TRAIL-mediated apoptosis and synergistically inhibits biomarkers associated with angiogenesis and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Prostate carcinoma and green tea: PSA-triggered basement membrane degradation and MMP-2 activation are inhibited by (-)epigallocatechin-3-gallate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Prostate carcinoma and green tea: (-)epigallocatechin-3-gallate inhibits inflammation-triggered MMP-2 activation and invasion in murine TRAMP model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

(-)-Epigallocatechin-3-gallate inhibits Met signaling, proliferation, and invasiveness in human colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Differential effects of antioxidants on the in vitro invasion, growth and lung metastasis of murine colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

(-)-Epigallocatechin-3-gallate (EGCG) inhibits HGF-induced invasion and metastasis in hypopharyngeal carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Epigallocatechin-3-gallate inhibits the invasion of human oral cancer cells and decreases the productions of matrix metalloproteinases and urokinase-plasminogen activator

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Effects of green tea polyphenol on methylation status of RECK gene and cancer cell invasion in oral squamous cell carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Effects of tea polyphenols on the invasion and matrix metalloproteinases activities of human fibrosarcoma HT1080 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Association of suppression of extracellular signal-regulated kinase phosphorylation by epigallocatechin gallate with the reduction of matrix metalloproteinase activities in human fibrosarcoma HT1080 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Tumor gelatinases and invasion inhibited by the green tea flavanol epigallocatechin-3-gallate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Suppression of human pancreatic carcinoma cell growth and invasion by epigallocatechin-3-gallate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Medulloblastoma cell invasion is inhibited by green tea (−)epigallocatechin‐3‐gallate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Inhibitory effect of epigallocatechin-3-gallate on growth and invasion in human biliary tract carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Mechanisms of inhibition of tumor angiogenesis and vascular tumor growth by epigallocatechin-3-gallate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Inhibition of melanoma growth and metastasis by combination with (-)-epigallocatechin-3-gallate and dacarbazine in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Inhibitory effect of epigallocatechin gallate on adhesion of murine melanoma cells to laminin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Inhibition of invasion and up-regulation of E-cadherin expression in human malignant melanoma cell line A375 by (-)-epigallocatechin-3-gallate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Epigallocatechin-3-gallate inhibits paracrine and autocrine hepatocyte growth factor/scatter factor-induced tumor cell migration and invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Estimated Asian adult soy protein and isoflavone intakes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Dietary flavonoids and colorectal adenoma recurrence in the Polyp Prevention Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Soy food consumption and risk of prostate cancer: a meta-analysis of observational studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Phyto-oestrogens, their mechanism of action: current evidence for a role in breast and prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Chemopreventive potential of epigallocatechin gallate and genistein: evidence from epidemiological and laboratory studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Mechanisms of cancer chemoprevention by soy isoflavone genistein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Genistein inhibits invasive potential of human hepatocellular carcinoma by altering cell cycle, apoptosis, and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Differential effects of isoflavones and lignans on invasiveness of MDA-MB-231 breast cancer cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

A novel anti-cancer effect of genistein: reversal of epithelial mesenchymal transition in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Antitumor and antimetastatic activities of docetaxel are enhanced by genistein through regulation of osteoprotegerin/receptor activator of nuclear factor-kappaB (RANK)/RANK ligand/MMP-9 signaling in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Identification of a biphasic role for genistein in the regulation of prostate cancer growth and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Genistein inhibits matrix metalloproteinase type 2 activation and prostate cancer cell invasion by blocking the transforming growth factor beta-mediated activation of mitogen-activated protein kinase-activated protein kinase 2-27-kDa heat shock prot

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

MEK4 function, genistein treatment, and invasion of human prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Genistein induces the metastasis suppressor kangai-1 which mediates its anti-invasive effects in TRAMP cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Epidermal growth factor (EGF)- and transforming growth factor alpha-stimulated invasion and growth of follicular thyroid cancer cells can be blocked by antagonism to the EGF receptor and tyrosine kinase in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Flavonoid antioxidant silymarin and skin cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Silibinin inhibits the invasion of human lung cancer cells via decreased productions of urokinase-plasminogen activator and matrix metalloproteinase-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Silibinin inhibits cell invasion through inactivation of both PI3K-Akt and MAPK signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Silibinin suppresses PMA-induced MMP-9 expression by blocking the AP-1 activation via MAPK signaling pathways in MCF-7 human breast carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Silibinin prevents TPA-induced MMP-9 expression and VEGF secretion by inactivation of the Raf/MEK/ERK pathway in MCF-7 human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Evaluation of silibinin on the viability, migration and adhesion of the human prostate adenocarcinoma (PC-3) cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Silibinin inhibits prostate cancer invasion, motility and migration by suppressing vimentin and MMP-2 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Silibinin inhibits invasion of oral cancer cells by suppressing the MAPK pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Silibinin inhibits the invasion and migration of renal carcinoma 786-O cells in vitro, inhibits the growth of xenografts in vivo and enhances chemosensitivity to 5-fluorouracil and paclitaxel

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Silibinin suppresses human osteosarcoma MG-63 cell invasion by inhibiting the ERK-dependent c-Jun/AP-1 induction of MMP-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Anti-oxidant effect of flavonoids on the susceptibility of LDL oxidation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Dietary flavonoids attenuate tumor necrosis factor alpha-induced adhesion molecule expression in human aortic endothelial cells. Structure-function relationships and activity after first pass metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Quercetin inhibition of tumor invasion via suppressing PKC delta/ERK/AP-1-dependent matrix metalloproteinase-9 activation in breast carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Inhibition of MMP-3 activity and invasion of the MDA-MB-231 human invasive breast carcinoma cell line by bioflavonoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Quercetin downregulates matrix metalloproteinases 2 and 9 proteins expression in prostate cancer cells (PC-3).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Quercetin inhibits invasion, migration and signalling molecules involved in cell survival and proliferation of prostate cancer cell line (PC-3).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

The flavonols quercetin, kaempferol, and myricetin inhibit hepatocyte growth factor-induced medulloblastoma cell migration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Contribution of reactive oxygen species to migration/invasion of human glioblastoma cells U87 via ERK-dependent COX-2/PGE(2) activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Effects of dietary flavonoids, luteolin, and quercetin on the reversal of epithelial-mesenchymal transition in A431 epidermal cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Quercetin inhibits the invasion of murine melanoma B16-BL6 cells by decreasing pro-MMP-9 via the PKC pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Luteolin promotes degradation in signal transducer and activator of transcription 3 in human hepatoma cells: an implication for the antitumor potential of flavonoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Inhibitory effect of luteolin on hepatocyte growth factor/scatter factor-induced HepG2 cell invasion involving both MAPK/ERKs and PI3K-Akt pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Inhibition of cell survival, invasion, tumor growth and histone deacetylase activity by the dietary flavonoid luteolin in human epithelioid cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Pomegranate (Punica granatum) pure chemicals show possible synergistic inhibition of human PC-3 prostate cancer cell invasion across Matrigel

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Luteolin inhibits invasion of prostate cancer PC3 cells through E-cadherin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

12-O-tetradecanoylphorbol-13-acetate-induced invasion/migration of glioblastoma cells through activating PKCalpha/ERK/NF-kappaB-dependent MMP-9 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Dietary flavonoids: bioavailability, metabolic effects, and safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Selective growth-inhibitory, cell-cycle deregulatory and apoptotic response of apigenin in normal versus human prostate carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Apigenin Induces Apoptosis through Proteasomal Degradation of HER2/neu in HER2/neu-overexpressing Breast Cancer Cells via the Phosphatidylinositol 3-Kinase/Akt-dependent Pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Apigenin induced apoptosis through p53-dependent pathway in human cervical carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Flavonoid apigenin inhibits motility and invasiveness of carcinoma cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Apigenin acts on the tumor cell invasion process and regulates protease production

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Apigenin inhibits HGF-promoted invasive growth and metastasis involving blocking PI3K/Akt pathway and beta 4 integrin function in MDA-MB-231 breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

The chemopreventive bioflavonoid apigenin inhibits prostate cancer cell motility through the focal adhesion kinase/Src signaling mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Apigenin inhibited migration and invasion of human ovarian cancer A2780 cells through focal adhesion kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

The red wine phenolics piceatannol and myricetin act as agonists for estrogen receptor alpha in human breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Flavonols and pancreatic cancer risk: the multiethnic cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Myricetin suppresses invasion and migration of human lung adenocarcinoma A549 cells: possible mediation by blocking the ERK signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Antiproliferative activity of flavonoids on several cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Effect of catechins and citrus flavonoids on invasion in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Anti-invasive activities of experimental chemotherapeutic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Evaluation of the effects of swainsonine, captopril, tangeretin and nobiletin on the biological behaviour of brain tumour cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Treatment of metastatic melanoma B16F10 by the flavonoids tangeretin, rutin, and diosmin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Enzymatic preparation of kaempferol from green tea seed and its antioxidant activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

A review on the dietary flavonoid kaempferol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Lipopolysaccharide plus 12-o-tetradecanoylphorbol 13-acetate induction of migration and invasion of glioma cells in vitro and in vivo: Differential inhibitory effects of flavonoids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Glycitein inhibits glioma cell invasion through down-regulation of MMP-3 and MMP-9 gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Antioxidant activity of anthocyanins and their aglycons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Cancer chemopreventive activity of resveratrol, a natural product derived from grapes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Induction of apoptosis in cancer cells by Bilberry (Vaccinium myrtillus) and the anthocyanins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Anti-angiogenic, antioxidant, and anti-carcinogenic properties of a novel anthocyanin-rich berry extract formula

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Mulberry anthocyanins, cyanidin 3-rutinoside and cyanidin 3-glucoside, exhibited an inhibitory effect on the migration and invasion of a human lung cancer cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Induction of apoptosis and inhibition of invasion in human hepatoma cells by anthocyanins from meoru

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Anti-invasive activity of anthocyanins isolated from Vitis coignetiae in human hepatocarcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Peonidin 3-glucoside inhibits lung cancer metastasis by downregulation of proteinases activities and MAPK pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Delphinidin inhibits cell proliferation and invasion via modulation of Met receptor phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Cyanidin-3-glucoside inhibits ethanol-induced invasion of breast cancer cells overexpressing ErbB2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Blueberry flavonoids inhibit matrix metalloproteinase activity in DU145 human prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Inhibition of matrix metalloproteinase activity in DU145 human prostate cancer cells by flavonoids from lowbush blueberry (Vaccinium angustifolium): possible roles for protein kinase C and mitogen-activated protein-kinase-mediated events

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Characterization of a profile of the anthocyanins isolated from Vitis coignetiae Pulliat and their anti-invasive activity on HT-29 human colon cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Anthocyanidins inhibit migration of glioblastoma cells: structure-activity relationship and involvement of the plasminolytic system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

EGCG inhibits growth, invasion, angiogenesis and metastasis of pancreatic cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Molecular mechanisms of action of angiopreventive anti-oxidants on endothelial cells: microarray gene expression analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

(-)-Epigallocatechin gallate inhibits membrane-type 1 matrix metalloproteinase, MT1-MMP, and tumor angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Genistein attenuates peritoneal metastasis of azoxymethane-induced intestinal adenocarcinomas in Wistar rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Dietary genistein inhibits metastasis of human prostate cancer in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Soy phytochemicals prevent orthotopic growth and metastasis of bladder cancer in mice by alterations of cancer cell proliferation and apoptosis and tumor angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Silibinin inhibits established prostate tumor growth, progression, invasion, and metastasis and suppresses tumor angiogenesis and epithelial-mesenchymal transition in transgenic adenocarcinoma of the mouse prostate model mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Stage-specific inhibitory effects and associated mechanisms of silibinin on tumor progression and metastasis in transgenic adenocarcinoma of the mouse prostate model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Silibinin strongly inhibits growth and survival of human endothelial cells via cell cycle arrest and downregulation of survivin, Akt and NF-kappaB: implications for angioprevention and antiangiogenic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Quercetin, a dietary-derived flavonoid, possesses antiangiogenic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Suppression by apigenin of peritoneal metastasis of intestinal adenocarcinomas induced by azoxymethane in Wistar rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Apigenin inhibits tumor angiogenesis through decreasing HIF-1alpha and VEGF expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Cyanidin-3-glucoside, a natural product derived from blackberry, exhibits chemopreventive and chemotherapeutic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Precise measurement of the E-cadherin repressor Snail in formalin-fixed endometrial carcinoma using protein lysate microarrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9347-Y

Induction of cell cycle arrest and apoptosis in HT-29 human colon cancer cells by the dietary compound luteolin

21 January 2018

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.1152/AJPGI.00248.2006

Identifiers

DOI

10.1007/S10555-012-9347-Y

1 reference

26 August 2017

1 reference

PubMed ID

22314287